Development of a scalable iridium-catalyzed asymmetric hydrogenation process for synthesis of chiral 2-methyl-1,2,3,4-tetrahydroquinoline
Chiral Chemistry · 2025
DOI: 10.70401/cc.2026.0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chiral Chemistry, 2025. Verfasst von Huan Jing und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Asymmetric hydrogenation is an efficient tool for rapid synthesis of a diverse range of chiral compounds with high yields and excellent enantioselectivities. Chiral 2-methyl-1,2,3,4-tetrahydro-quinoline is a valuable building block for organic synthesis and has been widely used in the synthesis of bioactive molecules and chiral ligands. Herein, we report an improved iridium-catalyzed asymmetric hydrogenation of 2-methylquinoline on a hundred-gram scale for efficient synthesis of chiral 2-methyl-1,2,3,4-tetrahydroquinoline with up to 91.4% ee value and an 80,000 turnover number. Optically pure 2-methyl-1,2,3,4-tetrahydroquinoline could be obtained in high yields through recrystallization or chemical resolution with the tartaric acid derivative (L)-DMTA.
Zitieren
APA
Jing, H., Yu, C., & Zhou, Y. (2025). Development of a scalable iridium-catalyzed asymmetric hydrogenation process for synthesis of chiral 2-methyl-1,2,3,4-tetrahydroquinoline. Chiral Chemistry. https://doi.org/10.70401/cc.2026.0010
Vancouver
Jing H, Yu C, Zhou Y. Development of a scalable iridium-catalyzed asymmetric hydrogenation process for synthesis of chiral 2-methyl-1,2,3,4-tetrahydroquinoline. Chiral Chemistry. 2025. doi:10.70401/cc.2026.0010
BibTeX
@article{Jing2025,
author = {Jing, Huan and Yu, Chang-Bin and Zhou, Yong-Gui},
title = {Development of a scalable iridium-catalyzed asymmetric hydrogenation process for synthesis of chiral 2-methyl-1,2,3,4-tetrahydroquinoline},
journal = {Chiral Chemistry},
year = {2025},
doi = {10.70401/cc.2026.0010}
}
EUVIMED